GLG Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

GLG Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-163,310	Closed	-$28.2M	–	557
2015 Q1	$28.2M	Buy	163,310 +131,738	+417%	+$19.3M	0.94%	28
2014 Q4	$3.63M	Sell	31,572 -18,428	-37%	-$2.23M	0.11%	189
2014 Q3	$7.81M	Buy	+50,000	New	+$7.25M	0.18%	160

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

GLG Partners's SLXP Position: Q2 2015 in Review

GLG Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 163,310 shares — an estimated $28.2M sold.

GLG Partners first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $28.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

GLG Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
GLG Partners sold 163,310 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $28.2M.
GLG Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
GLG Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $28.2M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on GLG Partners's 13F filing for Q2 2015, filed 14 Aug 2015.